Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Tanya L. Carleton, LAc
Tanya Carleton is an assistant clinical supervisor and the academic dean at the Colorado School of Traditional Chinese Medicine. She also practices at the Wisdom of the Ancients Clinic in Denver.